New ‘rinse and spit’ oral cancer test shows promise
A “rinse and spit” test for early detection of oral cancer performed well in a clinical feasibility study, according to Vigilant Biosciences, the company commercializing the product. The study, sponsored by the National Cancer Institute, included 300 subjects in a case-control design that ensured cases (oral cancer patients) and controls (volunteers without cancer) were similar with respect to other factors, such as tobacco and alcohol use, age, and race. It

